barbital has been researched along with Absence Seizure in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 45 (88.24) | 18.7374 |
1990's | 4 (7.84) | 18.2507 |
2000's | 2 (3.92) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DAVIDOFF, E; DOOLITTLE, GM | 1 |
OSGOOD, CW | 1 |
BARANY, EH; STEIN-JENSEN, E | 1 |
CAHEN, RL | 1 |
RISING, JD | 1 |
WAY, EL | 1 |
RUBINSTEIN, HS | 1 |
COLE, VV; HULPIEU, HR | 1 |
BELINKOFF, S | 1 |
ESSIG, CF; FLANARY, HG | 1 |
NIPPERT, F | 1 |
BROWNE, O | 1 |
KELLAWAY, P | 1 |
MERCIER, J | 1 |
BRODY, M | 1 |
RUSKIN, DB | 1 |
BELFORD, J; BONNYCASTLE, DD | 1 |
De Lima, TC; Palermo-Neto, J | 1 |
Hiramori, T; Nakao, K; Tagashira, E; Urano, T; Yanaura, S | 2 |
Persson, SA; Wahlström, G | 1 |
Hinman, DJ; Okamoto, M | 2 |
Bourn, WM; Garrett, RL | 1 |
Hiramori, T; Kuroiwa, Y; Nakao, K; Tagashira, E; Urano, T; Yanaura, S | 1 |
Capaz, FR; De Moraes, S; Saban, R | 1 |
Nordberg, A; Wahlström, G | 1 |
Larsson, C; Nordberg, A; Wahlström, G | 1 |
Flint, BA; Ho, IK | 1 |
Bourn, WM; Reigel, CE | 2 |
Butterworth, AR; Little, HJ; Rabbani, M; Wright, J; Zhou, Q | 1 |
Chakrabarti, A; Kansal, DK | 2 |
Blake, GJ; Gilbert, MB; Raines, A; Richardson, B | 1 |
Wahlström, G | 3 |
Hawkins, TD; Kant, GJ; Lenox, RH; Meyerhoff, JL; Wray, HL | 1 |
Larsson, R; Wahlström, G | 1 |
Bourn, WM; Gildea, ML | 1 |
Goldstein, DB; Siew, C | 1 |
Gonzales, EG; Morgan, WW; Pfeil, KA | 1 |
Helke, CJ; Raines, A | 1 |
Isom, GE; Mann, PA | 1 |
Beaver, RW; Brauer, RW; Lahser, S | 1 |
Morgan, WW | 1 |
Archer, T; Lärkfors, L; Wahlström, G | 1 |
McCaslin, PP; Morgan, WW | 1 |
Palermo-Neto, J; Sandoval, MR | 2 |
51 other study(ies) available for barbital and Absence Seizure
Article | Year |
---|---|
Use of delvinal sodium vinobarbital in the treatment of serial seizures and status epilepticus.
Topics: Barbital; Barbiturates; Seizures; Sodium; Status Epilepticus | 1948 |
Convulsive seizures following barbiturate withdrawal.
Topics: Barbital; Barbiturates; Behavior, Addictive; Humans; Psychoses, Substance-Induced; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1947 |
The action of di-allyl-barbituric acid on the electrically induced epileptic fit.
Topics: Anesthesia; Anesthesiology; Barbital; Barbiturates; Epilepsy; Humans; Seizures; Therapeutics | 1946 |
On the anticonvulsant activity of various nitrogen heterocycles; alkylthioetherbarbiturates and phenylalkylthiomethylhydantoins.
Topics: Anticonvulsants; Barbital; Barbiturates; Hydantoins; Nitrogen; Seizures; Spasm | 1946 |
The comparative value of pentothal sodium, curare, and magnesium sulfate for the modification of metrazol convulsions.
Topics: Anesthesia; Anesthesiology; Barbital; Curare; Magnesium; Magnesium Sulfate; Pentylenetetrazole; Seizures; Sodium; Thiopental | 1946 |
Barbiturate antagonism of isonipecaine convulsions and isonipecaine potentiation of barbiturate depression.
Topics: Aged; Barbital; Barbiturates; Depression; Humans; Isonipecotic Acids; Seizures | 1946 |
The fear-allaying effect of pentothal sodium in electro-shock therapy.
Topics: Barbital; Barbiturates; Convulsive Therapy; Fear; Seizures; Sodium; Therapeutics; Thiopental | 1946 |
A method for determining the relative anticonvulsive activity of barbiturates.
Topics: Barbital; Barbiturates; Humans; Seizures; Therapeutics | 1946 |
Convulsions during anesthesia treated with intravenous sodium pentothal.
Topics: Anesthesia; Anesthesiology; Barbital; Ether; Ethers; Iatrogenic Disease; Seizures; Sodium; Thiopental | 1946 |
Convulsions in cats following withdrawal of barbital sodium.
Topics: Animals; Barbital; Cats; Seizures; Sodium | 1959 |
[Prospects of epileptasid-luminal therapy of canine distemper convulsions].
Topics: Animals; Barbital; Distemper; Dogs; Seizures; Venoms | 1950 |
The treatment of eclampsia; preliminary report on the present Rotunda treatment of eclampsia by soluble sodium thiopentone and concentrated salt-free dextrose solution, with particular reference to the control of convulsions.
Topics: Barbital; Eclampsia; Female; Glucose; Pregnancy; Seizures; Sodium; Sodium Chloride; Sodium Chloride, Dietary; Thiopental | 1950 |
The use of sedative-induced sleep as an aid to electroencephalographic diagnosis in children.
Topics: Barbital; Electroencephalography; Hypnotics and Sedatives; Seizures; Sleep | 1950 |
[Molecular structure and anticonvulsive power. Effect of gardenal, metabromogardenal and sodium bromide on audiogenic crisis of the white rat].
Topics: Animals; Barbital; Bromides; Molecular Structure; Phenobarbital; Rats; Seizures; Sodium Compounds | 1950 |
Modification of the electroshock convulsion by means of curare, intravenous barbiturate and an airway.
Topics: Barbital; Barbiturates; Convulsive Therapy; Curare; Electroshock; Humans; Seizures | 1951 |
Comparative results in seizure control using phenobarbital, dilantin, and mesantoin.
Topics: Barbital; Epilepsy; Hydantoins; Mephenytoin; Phenobarbital; Phenytoin; Seizures | 1950 |
The effect of some anticonvulsant agents upon agene-induced convulsions in dogs.
Topics: Animals; Anticonvulsants; Barbital; Chlorides; Dogs; Nitrogen Compounds; Seizures | 1950 |
Effects of withdrawal from long-term barbital treatment on open-field behaviour and seizure susceptibility of rats.
Topics: Acoustic Stimulation; Animals; Barbital; Barbiturates; Behavior, Animal; Exploratory Behavior; Humans; Male; Motor Activity; Neurotransmitter Agents; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome | 1982 |
Participant of serotonin turnover rate in the brain on barbital withdrawal convulsion.
Topics: Animals; Barbital; Barbiturates; Brain; Chlorpromazine; Humans; Hydroxyindoleacetic Acid; Male; Nitrazepam; Phenytoin; Rats; Rats, Inbred Strains; Seizures; Serotonin; Substance Withdrawal Syndrome | 1982 |
Studies on interactions between striatal dopaminergic and cholinergic mechanisms in the early abstinence after chronic treatment with barbital in the rat.
Topics: Acetylcholine; Animals; Barbital; Barbiturates; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Seizures; Substance Withdrawal Syndrome | 1984 |
Cortical and subcortical EEG patterns during moderate-intensity barbiturate withdrawal.
Topics: Animals; Barbital; Barbiturates; Behavior, Animal; Cats; Cerebral Cortex; Electroencephalography; Female; Humans; Male; Seizures; Substance Withdrawal Syndrome | 1984 |
Physical dependence produced by long duration, low dose chronic barbital treatment.
Topics: Animals; Barbital; Barbiturates; Body Weight; Cats; Central Nervous System; Female; Humans; Male; Motor Activity; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1984 |
Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Humans; Male; Methyltyrosines; Pentylenetetrazole; Propranolol; Rats; Rats, Inbred Strains; Reserpine; Seizures; Serotonin; Substance Withdrawal Syndrome; Tranylcypromine | 1983 |
Increased susceptibility of audiogenic rats to barbital withdrawal convulsions.
Topics: Acoustic Stimulation; Animals; Barbital; Barbiturates; Disease Susceptibility; Humans; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome | 1983 |
Specific action of tranylcypromine to precipitate barbital withdrawal convulsions.
Topics: Animals; Barbital; Barbiturates; Humans; Monoamine Oxidase Inhibitors; Pentylenetetrazole; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome; Tranylcypromine | 1982 |
Adrenoceptor supersensitivity in the isolated rat vas deferens during barbital withdrawal.
Topics: Acoustic Stimulation; Animals; Barbital; Barbiturates; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Seizures; Substance Withdrawal Syndrome; Vas Deferens | 1982 |
Changes in populations of cholinergic binding sites in brain after chronic exposure to barbital in rats.
Topics: Animals; Barbital; Barbiturates; Binding Sites; Brain; Cerebral Cortex; Male; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Muscarinic; Seizures; Time Factors | 1982 |
Increased number of muscarinic binding sites in brain following chronic barbiturate treatment to rat.
Topics: Animals; Barbital; Barbiturates; Cerebellum; Corpus Striatum; Hippocampus; Humans; Male; Medulla Oblongata; Mesencephalon; Quinuclidinyl Benzilate; Rats; Receptors, Cholinergic; Receptors, Muscarinic; Seizures; Substance Withdrawal Syndrome; Synaptosomes | 1980 |
Continuous administration of barbital by pellet implantation.
Topics: Animals; Barbital; Barbiturates; Behavior, Animal; Body Temperature; Body Weight; Drug Implants; Drug Tolerance; Enzyme Induction; Humans; Male; Mice; Pentobarbital; Seizures; Sleep; Substance-Related Disorders | 1980 |
Effects of barbital or diazepam withdrawal on seizure thresholds to bicuculline, picrotoxin and flurazepam.
Topics: Animals; Barbital; Bicuculline; Convulsants; Diazepam; Flurazepam; Male; Picrotoxin; Rats; Rats, Sprague-Dawley; Seizures; Substance Withdrawal Syndrome | 1995 |
Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.
Topics: 2-Amino-5-phosphonovalerate; Animals; Barbital; Bicuculline; Cerebral Cortex; Dizocilpine Maleate; Hippocampus; Male; Mice; Motor Activity; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome | 1994 |
Cross-substitution of diazepam for barbital results in only a low incidence of audiogenic seizures upon withdrawal in dependent rats.
Topics: Acoustic Stimulation; Animals; Barbital; Diazepam; Male; Rats; Rats, Sprague-Dawley; Seizures; Substance Withdrawal Syndrome | 1994 |
An observational study on neurobehavioural effects of acute oxydemeton-methyl (insecticide and acaricide) exposure in rats.
Topics: Animals; Barbital; Behavior, Animal; Convulsants; Electroshock; Exploratory Behavior; Female; Hypnotics and Sedatives; Insecticides; Male; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Pentylenetetrazole; Postural Balance; Rats; Rats, Sprague-Dawley; Seizures | 2000 |
Neurobehavioural study of subchronic administration of oxydemeton-methyl (insecticide and acaricide) in rats.
Topics: Animals; Antipsychotic Agents; Barbital; Behavior, Animal; Catalepsy; Convulsants; Electroshock; Exploratory Behavior; Female; Haloperidol; Hypnotics and Sedatives; Insecticides; Male; Nervous System; Organothiophosphorus Compounds; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Seizures; Sleep; Time Factors | 2001 |
Differential selectivity of several barbiturates on experimental seizures and neurotoxicity in the mouse.
Topics: Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Male; Mice; Neuromuscular Diseases; Pentobarbital; Pentylenetetrazole; Phenobarbital; Seizures; Thiopental | 1979 |
The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
Topics: Animals; Atropine; Barbital; Barbiturates; Drug Tolerance; Electroencephalography; Hexobarbital; Humans; Male; Rats; Seizures; Substance Withdrawal Syndrome; Time Factors | 1978 |
Changes in brain levels of cyclic nucleotides and gamma-aminobutyric acid in barbiturate dependence and withdrawal.
Topics: Acoustic Stimulation; Animals; Barbital; Barbiturates; Brain; Cyclic AMP; Cyclic GMP; gamma-Aminobutyric Acid; Glutamates; Humans; Male; Rats; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1979 |
Activity pattern and convulsions in the abstinence period after barbital treatment in the rat.
Topics: Animals; Barbital; Barbiturates; Circadian Rhythm; Humans; Male; Motor Activity; Rats; Seizures; Substance Withdrawal Syndrome; Time Factors | 1977 |
The effect of delta-9-tetrahydrocannabinol on barbiturate withdrawal convulsions in the rat.
Topics: Acoustic Stimulation; Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Dronabinol; Humans; Male; Rats; Seizures; Substance Withdrawal Syndrome | 1977 |
Osmotic minipumps for administration of barbital to mice: demonstration of functional tolerance and physical dependence.
Topics: Animals; Barbital; Barbiturates; Drug Tolerance; Humans; Male; Mice; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1978 |
Effect of alpha-methyl-p-tyrosine on the incidence of spontaneous convulsions observed following barbital withdrawal.
Topics: Animals; Barbital; Barbiturates; Brain Chemistry; Dopamine; Humans; Male; Methyltyrosines; Norepinephrine; Pentylenetetrazole; Rats; Seizures; Substance Withdrawal Syndrome; Time Factors | 1978 |
Antiextensor effects of 3,3-diphenyl-n-propylamine in the mouse.
Topics: Animals; Barbital; Behavior, Animal; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Muscle Contraction; Pentobarbital; Pentylenetetrazole; Propylamines; Seizures; Sleep; Time Factors | 1978 |
A model for the rapid induction of barbiturate tolerance.
Topics: Animals; Barbital; Barbiturates; Brain; Drug Tolerance; Lethal Dose 50; Mice; Pentobarbital; Pentylenetetrazole; Seizures; Sleep | 1978 |
The interaction between electrically induced convulsions and tolerance in the abstinence period after chronic barbital treatments in the rat.
Topics: Animals; Barbital; Barbiturates; Drug Tolerance; Electroshock; Hexobarbital; Humans; Male; Rats; Seizures; Sleep; Substance Withdrawal Syndrome | 1976 |
Interaction of central nervous system effects of high pressures with barbiturates.
Topics: Animals; Atmosphere Exposure Chambers; Atmospheric Pressure; Barbital; Barbiturates; Female; Mice; Pentobarbital; Phenobarbital; Seizures; Time Factors | 1977 |
Effect of 6-hydroxydopamine pretreatment on spontaneous convulsions induced by barbital withdrawal.
Topics: Animals; Ascorbic Acid; Barbital; Barbiturates; Body Weight; Dopamine; Humans; Hydroxydopamines; Male; Norepinephrine; Rats; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders; Telencephalon | 1976 |
The interaction between spontaneous convulsions and tolerance to hexobarbital in the abstinence after chronic barbital treatments in the rat.
Topics: Animals; Barbital; Barbiturates; Drug Tolerance; Hexobarbital; Humans; Male; Rats; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1976 |
Nerve growth factor (NGF) in rat brain following long-term barbital treatment: relation to convulsions and cognitive function.
Topics: Animals; Barbital; Brain; Cerebral Cortex; Hippocampus; Learning Disabilities; Male; Nerve Growth Factors; Organ Size; Rats; Rats, Inbred Strains; Seizures; Spatial Behavior; Substance Withdrawal Syndrome | 1992 |
2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Aspartic Acid; Barbital; Barbiturates; Cerebellum; Cyclic GMP; Female; N-Methylaspartate; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1987 |
GABAergic influences on barbital withdrawal induced convulsions.
Topics: Animals; Barbital; Barbiturates; Corpus Striatum; gamma-Aminobutyric Acid; Male; Pentobarbital; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome; Time Factors | 1986 |
Central nervous system supersensitivity and withdrawal from long-term treatment with barbital.
Topics: Acoustic Stimulation; Animals; Barbital; Barbiturates; Brain; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome | 1985 |